A drug trial successfully cured participants from rectal cancer; pictured in context, people not relevant for this article. (Picture taken from freepik)
[Health Channel/Comprehensive Report]New progress in rectal cancer treatment! In a clinical trial of immunotherapy in 12 patients with stage 2-3 rectal cancer, treated with a monoclonal antibody called dostarlimab, all participants’ tumors disappeared, undetected and without serious side effects.
The research team said that this situation is unprecedented and very exciting, but more experiments are still needed to determine the effect, and there is still a distance from formal application.
Please read on…
Andrea Cercek, a member of the research team and an oncologist at Memorial Sloan Kettering Cancer Center in the United States, accepted the “CNN” said in the interview, this is absolutely amazing, we have never thought of this effect before the experiment, and we have never seen anything like it before.
It’s a cancer doctor’s dream come true to see a drug that works so well with few side effects, Sechek said. Patients feel well and function normally following receiving treatment, unlike other common cancer treatments that have significant side effects.
Secek explained that this is a type of immunotherapy (Immunotherapy), drugs fight cancer by unlocking the body’s immune system, allowing the body to recognize cancer cells, this type of immunotherapy is particularly effective for specific cancer cells in the rectum. dostarlimab allows the body’s immune system to recognize cancer cells and kill them.
The research has been published in the international journal “new england journal of medicineNEJM）。
☆Do not miss health news, follow by likefan page。
☆For more important medical news, please go toFree Health Network。
No need to draw, no need to grab, now use the APP to watch the news to ensure that you will win the lottery every dayClick me to download APP
Follow me to see how the event works
